Health NewsFeed

Health Newsfeed

AVANDIA WARNING



ANCHOR LEAD:  SHOULD PEOPLE STOP TAKING THE DIABETES MEDICATION CALLED AVANDIA?  ELIZABETH TRACEY REPORTS

Rosaglitazone is a diabetes medication marketed as Avandia.  The FDA has recently issued a warning about the drug, saying it causes an increase in the risk of heart attack in some patients who take it.  Sherita Golden, a diabetes expert at Johns Hopkins, says she has never considered the drug a first choice in the management of diabetes.

GOLDEN:  I think that this is still a drug that we consider here in the diabetes center to be a third line agent for the management of diabetes.  We typically will start therapy with a sulfonylurea or metformin, and you can always add insulin therapy to that, and so I think typically, at least in my practice I’ve used a drug like Avandia when patients have a resistance to starting insulin therapy.         :21

Golden says most patients with diabetes are carefully monitored for the development of heart problems since the condition itself is a risk factor for cardiovascular disease, but patients who are taking Avandia may require even more vigilance.  I’m Elizabeth Tracey reporting.


-- JHMI --
Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home